BioNTech SE BNTX
NASDAQ BNTX
$87.39 +0.18 (+0.21%)
As of: Nov 11, 2026 · 3:35 PM EST

BioNTech SE (BNTX) Change in Accrued Expenses (2018 - 2020)

Updated

BioNTech SE's Change in Accrued Expenses came in at -$19.61 million for Q1 2020, compared with -$22.92 million a year earlier.

Analysis

BioNTech SE (BNTX) Change in Accrued Expenses (2018 - 2020) Analysis & Trends

Over the trailing twelve months to Mar 31, 2020, BioNTech SE reported Change in Accrued Expenses of -$79.88 million; for FY2019, it was -$90.24 million.

  • Going back by year, Change in Accrued Expenses was -$24.9 million in FY2018 and -$5.17 million in FY2017.
  • The Q1 2020 figure represents the highest quarterly Change in Accrued Expenses since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BioNTech SE 22.05 Bn -37.46 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -19.61 Mn
Dec 31, 2019 -22.77 Mn
Mar 31, 2019 -22.92 Mn
Dec 31, 2018 -14.57 Mn
API Access

BioNTech SE Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BNTX&period=max&api_key=YOUR_API_KEY